Clinical Trials Logo

Clinical Trial Summary

Background:

- Cancer stem cells in breast cancer have been identified as a small population of tumor cells whose self-renewal mechanism is highly deregulated. This deregulation seems to be necessary for cancer to develop.

- These cells can be identified by certain surface markers that overlap with markers associated with normal embryonic stem cells.

Objective: To isolate tumor stem cells using the same methods generally used to isolate human embryonic stem cells.

Eligibility:

- Tissue samples will be obtained from the human cooperative network.

- Samples will include normal tissues from individuals who have no opportunistic diseases and from individuals with cancer.

Design: Breast cancer stem cells will be isolated, grown in the laboratory and characterized.


Clinical Trial Description

Cancers are composed of heterogeneous populations of cells with varying degrees of proliferative capacity and ability to reconstitute tumors when transplanted into nude or SCID mice.

Recently, cancer stem cells have been identified as a small population of tumor cells which possess the stem cell properties in that their self-renewal pathway is highly deregulated. This deregulation seems to be the prerequisite for the development of cancer. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00340392
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase N/A
Start date April 7, 2006
Completion date March 23, 2011

See also
  Status Clinical Trial Phase
Withdrawn NCT03629015 - Safety Study of Stemchymal® in Acute Liver Failure Phase 1
Not yet recruiting NCT04998461 - Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells
Completed NCT04132531 - Effect of Weight Loss Surgery on Stem Cells.
Completed NCT03381599 - Stem Cells After Peripheral Mobilization and Harvest Phase 1
Completed NCT02697682 - Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study N/A
Active, not recruiting NCT03874572 - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth Phase 1
Not yet recruiting NCT03361631 - Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes Phase 1
Not yet recruiting NCT03983902 - Placental Transfusion Methods and Stem Cells N/A
Completed NCT06219161 - The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations. N/A
Completed NCT04713436 - The Effects of Antibiotic Combinations on Stem Cells
Active, not recruiting NCT03028428 - Intra-articular Injection of MSCs in Treatment of Knee OA Phase 2
Recruiting NCT04646603 - MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients Phase 2
Withdrawn NCT02677350 - AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE) Phase 1
Terminated NCT00316069 - Stem Cell Collection